Research

Cord Blood Stem Cell Study Shows Promise for Autism

Posted on Feb 7, 2018 in Quality, Research, Uncategorized

SACRAMENTO, Calif. – A first-of-its-kind double-blinded, crossover study of children with autism who were treated with their own cord blood showed the treatment to be safe and suggests improvement in socialization.

Michael Chez, M.D., of Sutter Neuroscience Institute.

The study, which was published Feb. 6 in the medical journal Stem Cells Translational Medicine, involved 30 children and was conducted by Michael Chez, M.D., the primary investigator who designed the study that was carried out through the Sutter Neuroscience Institute of Sacramento and the Sutter Institute for Medical Research, with research grant funding by Cord Blood Registry® (CBR®). It was the first randomized, double-blinded, placebo-controlled trial performed in the United States to assess the feasibility of treating autistic children by using their own newborn cord blood harvested from their banked umbilical cord. The study can be viewed here.

Read More

Sutter Health Receives $3.2 Million Grant to Evaluate Type 2 Diabetes Prevention

Posted on Jan 19, 2018 in Quality, Research

Investment will help enhance and expand research efforts

 

PALO ALTO, Calif.—Sutter Health’s Palo Alto Medical Foundation Research Institute has secured funding from the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health to conduct a five-year study, evaluating the not-for-profit healthcare network’s experience with implementing Group Lifestyle Balance (GLB)™—a  group-based diabetes prevention program that has gained national attention for its success. Read More

Palo Alto Medical Foundation and Plusoptix Collaborate to Improve Vision Screening for Kids

Posted on Jan 10, 2018 in Quality, Research, Transformation

Easy to use, kids-friendly vision screening devices can help reduce the risk of lazy eye by more than 50 percent through comprehensive vision screening.1

 PALO ALTO, Calif.—Palo Alto Medical Foundation, an affiliate of Sutter Health , a leading not-for-profit health care system in Northern California, and Plusoptix, a world leader in instrument based vision screening, today announced they are working together to help improve routine vision screening for children in pediatric and family medicine clinics. More than 30 clinics at the Palo Alto Medical Foundation (PAMF) are utilizing vision screeners from Plusoptix as a way to ensure young children are thoroughly screened for eye disorders. Read More

Sutter Health Joins Cutting-Edge Study for Early Breast Cancer Detection

Posted on Sep 20, 2017 in Research, Transformation

Under the guidance of Sutter Health Research, several Sutter Health sites across Northern California are participating in a study that is evaluating a new tool for detection of early stage breast cancer.

The multicenter study, called the STRIVE Study, will evaluate a new blood test to be complementary to mammography for early detection of breast cancer. The test is being developed by GRAIL, Inc., and the study is recruiting women at mammography centers across the Sutter Health system and Mayo Clinic.

“The STRIVE Study is unprecedented in its size and scope, and has the potential to improve how we screen for breast cancer in the future,” said Walter “Buzz” Stewart, Ph.D., MPH, Sutter Health’s chief research officer. Read More

Sutter Health Joins IBM Watson Health Medical Imaging Collaborative

Posted on Feb 21, 2017 in Quality, Research

Sutter Health has joined the IBM Watson Health medical imaging collaborative to find ways to use the power of the Watson supercomputer to identify and predict the risk of cancer, diabetes, and diseases of the eye, brain and heart for patients.

The collaborative is designed to provide IBM Watson a real-world experience and share real-world findings because hospitals and health systems may employ different imaging machines, operational approaches or medical protocols.

Watson is a cloud-based system that analyzes high volumes of data, understands complex questions in everyday language, and proposes evidence-based answers. Watson continuously learns, gaining knowledge over time, from previous interactions. Read More

Sutter Health receives $1.2 million grant by California Initiative to Advance Precision Medicine

Posted on Nov 18, 2016 in Research

Partnership with UCSF researchers will support those living with multiple sclerosis

Walter “Buzz” Stewart, Ph.D., vice president and chief research officer for Sutter Health and MS-SHARE project lead

Walter “Buzz” Stewart, Ph.D., vice president and chief research officer for Sutter Health and MS-SHARE project lead

The not-for-profit Sutter Health network was awarded $1.2 million by the California Initiative to Advance Precision Medicine to support patients with multiple sclerosis—and help improve how we target and treat health matters across the entire state.

Sutter Health’s Research & Development team and colleagues from the University of California, San Francisco will jointly develop a software application called MS-SHARE. The neurology practice application will be used to improve the precision of care for multiple sclerosis (MS). Read More